Penumbra (PEN) Other Non Operating Income (2014 - 2023)
Penumbra's (PEN) quarterly Other Non Operating Income came in at -$444000.0 in Q3 2023, up 81.15% year-on-year from -$245094.7 in Q3 2022, and down 154.95% on a QoQ basis from $808000.0 in Q2 2023.
Penumbra (PEN) Other Non Operating Income (2014 - 2023) Analysis & Trends
Penumbra (PEN) has 10 years of Other Non Operating Income data on file, last reported at -$444000.0 in Q3 2023.
- On a quarterly basis, Other Non Operating Income rose 81.15% year-over-year to -$444000.0 in Q3 2023; TTM through Sep 2023 was $2.4 million, a 146.75% increase from a year earlier, with the FY2022 full-year figure at -$2.3 million, up 40.92% from the prior year.
- Other Non Operating Income for Q3 2023 stood at -$444000.0, down from $808000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for PEN reached as high as $2.0 million in Q4 2022 and fell as low as -$2.4 million in Q3 2022.
- Historically, Other Non Operating Income has averaged -$335894.7 across 5 years, with a median of -$408000.0 in 2021.
- Across the five-year window, Other Non Operating Income surged 1445.45% in 2019 and plunged 8221.43% in 2021, its largest moves.
- Year by year, Other Non Operating Income stood at $592000.0 in 2019, then jumped by 32.94% to $787000.0 in 2020, then slumped by 216.65% to -$918000.0 in 2021, then surged by 317.43% to $2.0 million in 2022, then plunged by 122.24% to -$444000.0 in 2023.
- Per Business Quant data, the three most recent Other Non Operating Income figures were -$444000.0 in Q3 2023, $808000.0 in Q2 2023, and $90000.0 in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -444,000.00 |
| Jun 30, 2023 | 808,000.00 |
| Mar 31, 2023 | 90,000.00 |
| Dec 31, 2022 | 2.00 Mn |
| Sep 30, 2022 | -2.36 Mn |
| Jun 30, 2022 | -956,000.00 |
| Mar 31, 2022 | -1.01 Mn |
| Dec 31, 2021 | -918,000.00 |
| Sep 30, 2021 | -1.14 Mn |
| Jun 30, 2021 | -408,000.00 |
| Mar 31, 2021 | -1.48 Mn |
| Dec 31, 2020 | 787,000.00 |
| Sep 30, 2020 | 14,000.00 |
| Jun 30, 2020 | 511,000.00 |
| Mar 31, 2020 | -1.66 Mn |
| Dec 31, 2019 | 592,000.00 |
| Sep 30, 2019 | -772,000.00 |
| Jun 30, 2019 | -71,000.00 |
| Mar 31, 2019 | 24,000.00 |
| Dec 31, 2018 | -44,000.00 |